Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -0.439% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) COc1cc(N=C2C(=O)N3c4c(cccc42)C(C)=CC3(C)C)cc(OC)c1
b.) Cc1cccn2c(=O)c3cc(C(=O)N4CCCC(C)C4)sc3nc12
Answer: b. Cc1cccn2c(=O)c3cc(C(=O)N4CCCC(C)C4)sc3nc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccn2c(=O)c3cc(C(=O)N4CCCC(C)C4)sc3nc12
Cc1cccn2c(=O)c3cc(C(=O)N4CCCC(C)C4)sc3nc12
10-methyl-5-(3-methylpiperidine-1-carbonyl)-6-thia-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaen-2-one